GENE ONLINE|News &
Opinion
Blog

2025-06-14|

Webinar on June 29 Explores Strategies for Scaling Digital Health Solutions in Pharma Industry

by Mark Chiang
Share To

A recent webinar held on June 29, 2023, addressed the growing challenges and opportunities for scaling digital health solutions within the pharmaceutical industry. The event, titled “Realise Global Scale for Your Digital Health Solution,” was part of the Pharma Digital Health Europe 2023 series and focused on strategies to overcome barriers to access while creating a blueprint for large-scale commercialization. Key topics included regulatory uncertainty, market access ambiguity, and infrastructural issues that hinder widespread adoption of digital health innovations.

The webinar highlighted several critical areas for discussion. Participants explored methods to develop scalable blueprints for digital health pilots that demonstrate return on investment (ROI) and integrate data insights into commercial strategies. Achieving cross-regional patient and healthcare provider engagement was emphasized as essential for ensuring referral pathways and broad buy-in. Additionally, the session examined co-creation with policymakers and payers to establish frameworks that expand access to larger patient populations. Interoperability was identified as a vital component in resolving infrastructure bottlenecks within the digital health value chain. The event aimed to equip attendees with actionable insights to navigate the complexities of scaling digital health solutions globally.

For those interested in accessing the full webinar recording, it is available online at [Vimeo](http://vimeo.com/841159596).

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: July 19, 2023

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
LATEST
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Retired DEA Judge John Mulrooney and Attorney Andrew Hull to Present on Controlled Substances at January 2026 ACI Summit
2026-01-12
Thermal Cycloaddition Achieves Synthesis of Gem-Difluoro Bicycloalkanes for Medicinal Chemistry
2026-01-12
Study Explores Gene Expression Changes in Freeze-Tolerant Vertebrates During Subzero Conditions
2026-01-12
Study Explores Water-Use Efficiency and Heat Tolerance in Lasiurus sindicus for Survival in Arid Ecosystems
2026-01-12
Researchers Design Multi-Epitope Vaccine Candidate for Vibrio fluvialis Using Immunoinformatics Tools
2026-01-12
CRISPR Technique Targets GGC Repeat Expansions in NOTCH2NLC Gene to Address Neuronal Intranuclear Inclusion Disease
2026-01-12
EVENT
2026-01-12
J.P. Morgan Healthcare Conference
San Francisco, California
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top